Xia & He Publishing Inc. Background and objectives Infection with HPV16, a high-risk human papillomavirus (HPV), can cause cervical cancer in humans. These infections carry a high risk of morbidity and mortality globally in females. This study aimed to conduct an in vivo comparison of Poly (D,L-lactic-co-glycolide) (PLGA)-encapsulated peptide mixture nanoparticles and PLGA microspheres as delivery systems...
Tag: <span>human papilloma virus (HPV)</span>
Post
New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach
Canadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer, suggests new modeling in Canadian Medical Association Journal. “Our results have important policy implications in Canada, and in other similar high-income countries evaluating whether to switch to 1-dose HPV vaccination,” writes Dr. Marc Brisson, a full professor at...
Post
Innovative diagnostic test could revolutionise cervical cancer screening
Coinciding with Cervical Cancer Prevention Week, researchers at St George’s are working on a field study to fine-tune an exciting new method of human papilloma virus testing that could revolutionise care for women in low and middle income countries. Credit: St. George’s University of London The research team have partnered with molecular diagnostics firm QuantuMDx...
Post
Catch-up HPV vaccine effective for women aged up to 20 years, US study suggests
US study confirms effectiveness of quadrivalent human papillomavirus (HPV) vaccine in women aged up to 20 years who receive all three doses, but more research is needed in women aged 21-26 years. Electron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domain For women aged 14-20 years, catch-up HPV...
Post
New study finds improved vaccine that protects against nine types of HPV is highly effective
Electron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations. The advent of human papillomavirus (HPV) vaccines has significantly...